Fatigue, inflammation, and-γ3 and γ-6 fatty acid intake among breast cancer survivors

Journal of Clinical Oncology

Volumn 30, Issue 12, 2012, Pages 1280-1287

  Alfano, Catherine M ^a   Imayama, Ikuyo ^b   Neuhouser, Marian L ^b   Kiecolt Glaser, Janice K ^d   Smith, Ashley Wilder ^a   Meeske, Kathleen ^e   McTiernan, Anne ^b,c   Bernstein, Leslie ^f   Baumgartner, Kathy B ^g   Ulrich, Cornelia M ^b,h   Ballard Barbash, Rachel ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^g UNIVERSITY OF LOUISVILLE   (United States)

^h GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SERUM AMYLOID A; TAMOXIFEN; AUTACOID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER FATIGUE; CANCER REGISTRY; CANCER SURVIVOR; COGNITION; COMORBIDITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; HEALTH BEHAVIOR; HUMAN; INFLAMMATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SHORT FORM 36; STROKE; ANALYSIS OF VARIANCE; BLOOD; BREAST TUMOR; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; FATIGUE; INTRADUCTAL CARCINOMA; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; RISK; RISK ASSESSMENT; STATISTICAL MODEL; SURVIVOR; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; C-REACTIVE PROTEIN; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COHORT STUDIES; DIETARY SUPPLEMENTS; FATIGUE; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK ASSESSMENT; SERUM AMYLOID A PROTEIN; SURVIVORS; TREATMENT OUTCOME;

EID: 84860382104     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.36.4109     Document Type: Article

References (60)

1. Barton-Burke M: Cancer-related fatigue and sleep disturbances. Am J Nurs 106:72-77, 2006
2. Lawrence DP, Kupelnick B, Miller K, et al: Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr 32:40-50, 2004
3. Bower JE, Ganz PA, Desmond KA, et al: Fatigue in long-term breast carcinoma survivors: A longitudinal investigation. Cancer 106:751-758, 2006 (Pubitemid 43238440)
4. Carpenter JS, Elam JL, Ridner SH, et al: Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum 31:591-5598, 2004
5. Stepanski EJ, Walker MS, Schwartzberg LS, et al: The relation of trouble sleeping, depressed mood, pain, and fatigue in patients with cancer. J Clin Sleep Med 5:132-136, 2009
6. Roscoe JA, Kaufman ME, Matteson-Rusby SE, et al: Cancer-related fatigue and sleep disorders. Oncologist 12:35-42, 2007 (suppl 1)
7. Bower JE, Ganz PA, Desmond KA, et al: Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743-753, 2000 (Pubitemid 30106604)
8. Alexander S, Minton O, Andrews P, et al: A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. Eur J Cancer 45:384-392, 2009
9. Donovan KA, Jacobsen PB: Fatigue, depression, and insomnia: Evidence for a symptom cluster in cancer. Semin Oncol Nurs 23:127-135, 2007
10. Curt GA, Breitbart W, Cella D, et al: Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. Oncologist 5:353-360, 2000
11. Bower JE, Ganz PA, Tao ML, et al: Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res 15:5534-5540, 2009
12. Schubert C, Hong S, Natarajan L, et al: The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review. Brain Behav Immun 21:413-427, 2007 (Pubitemid 46528677)
13. Miller AH, Ancoli-Israel S, Bower JE, et al: Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 26:971-982, 2008 (Pubitemid 351409339)
14. Lee BN, Dantzer R, Langley KE, et al: A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 11:279-292, 2004 (Pubitemid 39194326)
15. Collado-Hidalgo A, Bower JE, Ganz PA, et al: Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 12:2759-2766, 2006
16. Cleeland CS, Bennett GJ, Dantzer R, et al: Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokineimmunologic model of cancer symptoms. Cancer 97:2919-2925, 2003 (Pubitemid 36605163)
17. Bower JE, Ganz PA, Irwin MR, et al: Fatigue and gene expression in human leukocytes: Increased NF-kappaB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain Behav Immun 25:147-150, 2011
18. Ferrucci L, Cherubini A, Bandinelli S, et al: Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 91:439-446, 2006 (Pubitemid 43236907)
19. Micallef MA, Munro IA, Garg ML: An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. Eur J Clin Nutr 63:1154-1156, 2009
20. Makhoul Z, Kristal AR, Gulati R, et al: Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik Eskimos. Am J Clin Nutr 91:777-785, 2011
21. Murakami K, Sasaki S, Takahashi Y, et al: Total n-3 polyunsaturated fatty acid intake is inversely associated with serum C-reactive protein in young Japanese women. Nutr Res 28:309-314, 2008 (Pubitemid 351609208)
22. He K, Liu K, Daviglus ML, et al: Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol 103:1238-1243, 2009
23. Kalogeropoulos N, Panagiotakos DB, Pitsavos C, et al: Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clin Chim Acta 411:584-591, 2010
24. Madsen T, Skou HA, Hansen VE, et al: C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol 88:1139-1142, 2001 (Pubitemid 33043846)
25. Farzaneh-Far R, Harris WS, Garg S, et al: Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 205:538-543, 2009
26. Endres S, Ghorbani R, Kelley VE, et al: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320:265-271, 1989 (Pubitemid 19045549)
27. Caughey GE, Mantzioris E, Gibson RA, et al: The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63:116-122, 1996 (Pubitemid 26005735)
28. Meydani SN, Endres S, Woods MM, et al: Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: Comparison between young and older women. J Nutr 121:547-555, 1991
29. Endres S, Meydani SN, Ghorbani R, et al: Dietary supplementation with n-3 fatty acids suppresses interleukin-2 production and mononuclear cell proliferation. J Leukoc Biol 54:599-603, 1993
30. Faintuch J, Horie LM, Barbeiro HV, et al: Systemic inflammation in morbidly obese subjects: Response to oral supplementation with alphalinolenic acid. Obes Surg 17:341-347, 2007 (Pubitemid 46659294)
31. Barber MD, Ross JA, Preston T, et al: Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weightlosing patients with advanced pancreatic cancer. J Nutr 129:1120-1125, 1999 (Pubitemid 29250159)
32. Nakamura K, Kariyazono H, Komokata T, et al: Influence of preoperative administration of omega-3 fatty acid-enriched supplement on inflammatory and immune responses in patients undergoing major surgery for cancer. Nutrition 21:639-649, 2005 (Pubitemid 40733556)
33. Cerchietti LC, Navigante AH, Castro MA: Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer. Nutr Cancer 59:14-20, 2007 (Pubitemid 47549776)
34. Liang B, Wang S, Ye YJ, et al: Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients. World J Gastroenterol 14:2434-2439, 2008 (Pubitemid 351877620)
35. McTiernan A, Rajan KB, Tworoger SS, et al: Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 21:1961-1966, 2003 (Pubitemid 46606384)
36. Marchbanks PA, McDonald JA, Wilson HG, et al: The NICHD Women's Contraceptive and Reproductive Experiences Study: Methods and operational results. Ann Epidemiol 12:213-221, 2002 (Pubitemid 34414934)
37. Meeske K, Press M, Patel A, et al: Impact of reproductive factors and lactation on breast carcinoma in situ risk. Int J Cancer 110:102-109, 2004 (Pubitemid 38507209)
38. Piper BF, Dibble SL, Dodd MJ, et al: The revised Piper Fatigue Scale: Psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25:677-684, 1998
39. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473-483, 1992
40. Campbell PT, Campbell KL, Wener MH, et al: A yearlong exercise intervention decreases CRP among obese postmenopausal women. Med Sci Sports Exerc 41:1533-1539, 2009
41. Patterson RE, Kristal AR, Tinker LF, et al: Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 9:178-187, 1999 (Pubitemid 29144458)
42. Wayne SJ, Neuhouser ML, Ulrich CM, et al: Dietary fiber is associated with serum sex hormones and insulin-related peptides in postmenopausal breast cancer survivors. Breast Cancer Res Treat 112:149-158, 2008
43. Kriska AM, Bennett PH: An epidemiological perspective of the relationship between physical activity and NIDDM: From activity assessment to intervention. Diabetes Metab Rev 8:355-372, 1992 (Pubitemid 23171183)
44. Pereira MA, FitzerGerald SJ, Gregg EW, et al: A collection of Physical Activity Questionnaires for health-related research. Med Sci Sports Exerc 29:S1-S205, 1997 (suppl)
45. Danese A, Pariante CM, Caspi A, et al: Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci U S A 104:1319-1324, 2007 (Pubitemid 46184002)
46. Prasad K: C-reactive protein (CRP)-lowering agents. Cardiovasc Drug Rev 24:33-50, 2006
47. Ridker PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107:363-369, 2003
48. Segerstrom SC: Biobehavioral controls: Threats to psychoneuroimmunology research? Brain Behav Immun 23:885-886, 2009
49. O'Connor MF, Bower JE, Cho HJ, et al: To assess, to control, to exclude: Effects of biobehavioral factors on circulating inflammatory markers. Brain Behav Immun 23:887-897, 2009
50. Wener MH, Daum PR, McQuillan GM: The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol 27:2351-2359, 2000
51. Bordeleau L, Pritchard K, Goodwin P, et al: Therapeutic options for the management of hot flashes in breast cancer survivors: An evidencebased review. Clin Ther 29:230-241, 2007 (Pubitemid 46661858)
52. Pierce BL, Ballard-Barbash R, Bernstein L, et al: Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 27:3437-3444, 2009
53. Libby P: Inflammation in atherosclerosis. Nature 420:868-874, 2002
54. MacLean CH, Newberry SJ, Mojica WA, et al: Effects of Omega-3 Fatty Acids on Cancer. Summary, Evidence Report/Technology Assessment No 113 (Prepared by the Southern California Evidence-Based Practice Center under Contract No. 290-02-0003). Rockville, MD, Agency for Healthcare Research and Quality, AHRQ publication 05-E010-1, 2005
55. Appleton KM, Rogers PJ, Ness AR: Is there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? A review of the evidence to date from epidemiological studies, clinical studies and intervention trials. Nutr Res Rev 21:13-41, 2008
56. Monahan KD, Wilson TE, Ray CA: Omega-3 fatty acid supplementation augments sympathetic nerve activity responses to physiological stressors in humans. Hypertension 44:732-738, 2004 (Pubitemid 39435246)
57. Maes M, Mihaylova I, Leunis JC: In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation. Neuro Endocrinol Lett 26:745-751, 2005
58. Burns T, Maciejewski SR, Hamilton WR, et al: Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio. Pharmacotherapy 27:633-638, 2007 (Pubitemid 46700954)
59. Pierce BL, Neuhouser ML, Wener MH, et al: Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat 114:155-167, 2009
60. Poole S, Walker D, Gaines Das RE, et al: The first international standard for serum amyloid A protein (SAA): Evaluation in an international collaborative study. J Immunol Methods 214:1-10, 1998 (Pubitemid 28335533)